Results 61 to 70 of about 58,375 (292)

Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools

Biomedicines, 2016
For treatment of systemic malignancies, when external radiation therapy is not applicable, radionuclide therapy can be an alternative. In this form of therapy, radionuclides are administered to the patient, often in a form where the radionuclide is ...
Michael Ljungberg, Katarina Sjögreen Gleisner   +1 more
doaj   +1 more source

Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow

Терапевтический архив, 2021
Over the past 40 years, nuclear medicine has grown to be the largest non-invasive diagnostic and therapeutic industry in the world, playing a pivotal role in various fields and disciplines of clinical practice and contributing to improved quality of life
Vladimir B. Sergienko, Aleksei A. Ansheles   +1 more
doaj   +1 more source

Early Diagnosis of Alzheimer's disease by NIRF Spectroscopy and Nuclear Medicine [PDF]

, 2011
There is an urgent need for the early detection of diseases such as Alzheimer’s (AD) and Cancers in order to enable their successful treatment. Cancer is the second major cause of death after Heart Disease, and AD is the third major cause of death
I. C. Baianu
core   +1 more source

First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy. [PDF]

, 2018
PURPOSE: To investigate the utility of 153Sm lexidronam (Quadramet) in the setting of men with prostate cancer status post radical prostatectomy who develop biochemical failure with no clinical evidence of osseous metastases.
Girvigian, Michael R., Hoffman-Censits, Jean, Ko, Eric C., Pugh, Stephanie L., Rosenthal, Seth A., Sandler, Howard M., Sartor, Oliver, Schallenkamp, John, Shaves, Mark E., Trabulsi, Edouard J., Valicenti, Richard K.   +10 more
core   +2 more sources

Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family [PDF]

, 2020
Head and neck paragangliomas are the most common clinical features of familial paraganglioma syndrome type 1 caused by succinate dehydrogenase complex subunit D (SDHD) mutation. The clinical management of this syndrome is still unclear.
Cantisani, Vito, Colao, Annamaria, Di Leo, Nicola, Faggiano, Antongiulio, Feola, Tiziana, Giannetta, Elisa, Isidori, Andrea M, Lenzi, Andrea, Modica, Roberta, Polti, Giorgia, Puliani, Giulia, Sesti, Franz, Verrico, Monica   +12 more
core   +1 more source

Highly Efficient Extraction of 212 Pb/212Bi from the Decay Chain of 232Th‐Based on Anion Exchange in Bromide Medium

Advanced Science, EarlyView.
This work provides an effective strategy for selectively extracting 212Pb and 212Bi from the decay chain of 232Th as well as its mechanism illustration. Using the novel strategy, 2.07 MBq of 212Pb is successfully separated from 232Th and its daughters, which enables the supply of 212Pb/212Bi directly from the abundant natural thorium resource to be ...
Lifeng Chen, Wannian Feng, Yuezhou Wei, Xuexiang He, Shaoying Wang, Zhongyuan Zhou, Qiang Wu, Ningchao Zheng, Xiangbiao Yin, Wenlong Li, Lingling Su, Shunyan Ning   +11 more
wiley   +1 more source

It is time to move forward into the era of Theranostics

EJNMMI Research, 2018
Radionuclide therapy, which until 15 years ago included only a few approved therapies, is gaining importance in the treatment of various malignancies. The future of oncology will not be limited to surgery, chemo-, antibody therapies or external radiation;
Hojjat Ahmadzadehfar, Markus Essler
doaj   +1 more source

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy

Frontiers in Medicine, 2021
Samarium-153 (153Sm) is a highly interesting radionuclide within the field of targeted radionuclide therapy because of its favorable decay characteristics.
Michiel Van de Voorde, Charlotte Duchemin, Charlotte Duchemin, Reinhard Heinke, Reinhard Heinke, Laura Lambert, Eric Chevallay, Thomas Schneider, Miranda Van Stenis, Thomas Elias Cocolios, Thomas Cardinaels, Thomas Cardinaels, Bernard Ponsard, Maarten Ooms, Thierry Stora, Andrew R. Burgoyne   +15 more
doaj   +1 more source

Activation cross-sections of longer lived products of deuteron induced nuclear reactions on ytterbium up to 40 MeV

, 2013
In the frame of a systematic study of the activation cross-sections of the deuteron induced nuclear reactions, excitation functions of the natYb(d,xn)177,173,172mg,171mg,170,169Lu, natYb(d,x)175,169Yb and natYb(d,x)173,172,168,167,165Tm reactions are ...
Baba, M., Ditrói, F., Hermanne, A., Ignatyuk, A. V., Mohammadi, A., Takács, S., Tárkányi, F., Yamazaki, H.   +7 more
core   +1 more source

Precautions for certain categories of individuals in contact with a patient after radionuclide therapy

Радиационная гигиена
Patients undergoing radionuclide therapy with radiopharmaceuticals may become a radiation source of external exposure. Release of the patients requires strict abidance of radiation safety regulations to minimize exposure to individuals in contact with ...
L. A. Chipiga, A. V. Likhacheva, I. A. Zvonova, A. V. Vodovatov, O. Yu. Toskin, A. A. Sapelnikov, K. S. Velichkina, A. S. Terenteva, A. A. Stanzhevsky   +8 more
doaj   +1 more source